Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maryjane A Farr

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
JACC. Heart Failure|March 14, 2021
ECMO as a Bridge to Left Ventricular Assist Device or Heart TransplantationErsilia M DeFilippis, Kevin Clerkin, Lauren K Truby, et al.
Journal of the American Heart Association|June 26, 2018
Prevalence, Predictors, and Prognostic Value of Residual Tricuspid Regurgitation in Patients With Left Ventricular Assist DeviceKoki Nakanishi, Shunichi Homma, Jiho Han, et al.
The American Journal of Cardiology|December 21, 2022
Hemodynamic Gain Index and Exercise Capacity in Heart Failure With Preserved Ejection FractionVicente Morales-Oyarvide, Donald Richards, Nicholas S Hendren, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 23, 2014
Neutrophil gelatinase-associated lipocalin and cystatin C for the prediction of clinical events in patients with advanced heart failure and after ventricular assist device placementKatherine B Pronschinske, Sylvia Qiu, Christina Wu, et al.
Clinical Transplantation|March 22, 2022
Impact of socioeconomic deprivation on evaluation for heart transplantation at an urban academic medical centerErsilia M DeFilippis, Kevin J Clerkin, Raymond C Givens, et al.
Transplantation Direct|November 30, 2017
Comparative Assessment of Anti-HLA Antibodies Using Two Commercially Available Luminex-Based AssaysKevin J Clerkin, Sarah B See, Maryjane A Farr, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 23, 2021
Transcriptomic heterogeneity of antibody mediated rejection after heart transplant with or without donor specific antibodiesBenjamin S Mantell, Hector Cordero, Sarah B See, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 20, 2020
Profiling non-HLA antibody responses in antibody-mediated rejection following heart transplantationSarah B See, Benjamin S Mantell, Kevin J Clerkin, et al.
JACC. Heart Failure|December 31, 2021
Impact of Temporary Percutaneous Mechanical Circulatory Support Before Transplantation in the 2018 Heart Allocation SystemKevin J Clerkin, Oluwafeyijimi Salako, Justin A Fried, et al.
Circulation. Heart Failure|September 8, 2020
Psychosocial Risk and Its Association With Outcomes in Continuous-Flow Left Ventricular Assist Device PatientsErsilia M DeFilippis, Khadijah Breathett, Elena M Donald, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
JACC. Heart Failure|March 14, 2021
ECMO as a Bridge to Left Ventricular Assist Device or Heart TransplantationErsilia M DeFilippis, Kevin Clerkin, Lauren K Truby, et al.
Journal of the American Heart Association|June 26, 2018
Prevalence, Predictors, and Prognostic Value of Residual Tricuspid Regurgitation in Patients With Left Ventricular Assist DeviceKoki Nakanishi, Shunichi Homma, Jiho Han, et al.
The American Journal of Cardiology|December 21, 2022
Hemodynamic Gain Index and Exercise Capacity in Heart Failure With Preserved Ejection FractionVicente Morales-Oyarvide, Donald Richards, Nicholas S Hendren, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 23, 2014
Neutrophil gelatinase-associated lipocalin and cystatin C for the prediction of clinical events in patients with advanced heart failure and after ventricular assist device placementKatherine B Pronschinske, Sylvia Qiu, Christina Wu, et al.
Clinical Transplantation|March 22, 2022
Impact of socioeconomic deprivation on evaluation for heart transplantation at an urban academic medical centerErsilia M DeFilippis, Kevin J Clerkin, Raymond C Givens, et al.
Transplantation Direct|November 30, 2017
Comparative Assessment of Anti-HLA Antibodies Using Two Commercially Available Luminex-Based AssaysKevin J Clerkin, Sarah B See, Maryjane A Farr, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 23, 2021
Transcriptomic heterogeneity of antibody mediated rejection after heart transplant with or without donor specific antibodiesBenjamin S Mantell, Hector Cordero, Sarah B See, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 20, 2020
Profiling non-HLA antibody responses in antibody-mediated rejection following heart transplantationSarah B See, Benjamin S Mantell, Kevin J Clerkin, et al.
JACC. Heart Failure|December 31, 2021
Impact of Temporary Percutaneous Mechanical Circulatory Support Before Transplantation in the 2018 Heart Allocation SystemKevin J Clerkin, Oluwafeyijimi Salako, Justin A Fried, et al.
Circulation. Heart Failure|September 8, 2020
Psychosocial Risk and Its Association With Outcomes in Continuous-Flow Left Ventricular Assist Device PatientsErsilia M DeFilippis, Khadijah Breathett, Elena M Donald, et al.
Pageof 7